INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 58 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $33,364 | +31.6% | 158,500 | 0.0% | 0.00% | +33.3% |
| Q1 2023 | $25,360 | -71.2% | 158,500 | 0.0% | 0.00% | -72.7% |
| Q4 2022 | $87,968 | -73.3% | 158,500 | +8.4% | 0.01% | -77.1% |
| Q4 2021 | $329,000 | -34.2% | 146,200 | 0.0% | 0.05% | -42.2% |
| Q3 2021 | $500,000 | +37.4% | 146,200 | +20.0% | 0.08% | +31.7% |
| Q2 2021 | $364,000 | +134.8% | 121,800 | +66.4% | 0.06% | +96.9% |
| Q4 2020 | $155,000 | – | 73,200 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 6,575,000 | $21,237,000 | 2.26% |
| AIGH Capital Management LLC | 1,650,256 | $5,330,000 | 1.12% |
| BVF INC/IL | 8,383,645 | $27,079,000 | 1.02% |
| GUARDIAN POINT CAPITAL, LP | 1,200,000 | $3,876,000 | 0.97% |
| Tri Locum Partners LP | 1,210,863 | $3,911,000 | 0.97% |
| Altium Capital Management LP | 972,327 | $3,141,000 | 0.87% |
| Worth Venture Partners, LLC | 387,141 | $1,250,000 | 0.61% |
| DAFNA Capital Management LLC | 459,260 | $1,483,000 | 0.35% |
| SABBY MANAGEMENT, LLC | 530,000 | $1,712,000 | 0.33% |
| KNIGHTSBRIDGE ASSET MANAGEMENT, LLC | 173,110 | $559,000 | 0.24% |